Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors

Shaun Fell*, Zhuo Wang, Andy Blanchard, Carmel Nanthakumar, Martin Griffin*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry